| Description |
Tetracaine is a topical local anesthetic for the eyes; works by interfering with entry of sodium ions into nerve cells. |
| Related Catalog |
Signaling Pathways >>
Membrane Transporter/Ion Channel >>
Sodium Channel
Research Areas >>
Neurological Disease
|
| Solvent |
In Vitro: DMSO : ≥ 43 mg/mL (162.66 mM) * "≥" means soluble, but saturation unknown.
|
| Solubility |
1 mM3.7827 mL18.9136 mL37.8272 mL5 mM0.7565 mL3.7827 mL7.5654 mL10 mM0.3783 mL1.8914 mL3.7827 mL
|
| Storage |
Powder-20°C3 years 4°C2 yearsIn solvent-80°C6 months -20°C1 month
|
| Shipping |
Room temperature in continental US; may vary elsewhere
|
| SMILES |
O=C(OCCN(C)C)C1=CC=C(NCCCC)C=C1
|
| Related Molecules |
EIPA
|
Riluzole
|
Ginsenoside Rg3
|
Cariporide
|
Eleclazine hydrochloride
|
GS967
|
Tenapanor
|
Triamterene
|
Ranolazine dihydrochloride
|
PF 05089771
|
flecainide acetate
|
A-803467
|
CNV1014802 (hydrochloride)
|
Zonisamide
|
Cinchocaine
|
China
